The INSERV, KAMINO, KAMINO-2, and KAMINO-3 series (2014-2021) form a continuous thread of EEN service delivery for SME Instrument and EIC beneficiaries.
STEINBEIS TRANSFER GMBH
German technology transfer consultancy specializing in EEN Key Account Management and innovation strategy for EU-funded SMEs and EIC beneficiaries.
Their core work
Steinbeis Transfer GmbH is a Stuttgart-based technology transfer and innovation consultancy that helps SMEs access EU funding instruments and improve their innovation capacity. Their core H2020 work revolves around delivering Enterprise Europe Network (EEN) services — specifically Key Account Management for SME Instrument and EIC Accelerator beneficiaries, guiding companies through post-award innovation strategy development and commercialization. Beyond EEN support, they contribute consulting expertise to select research projects in health data infrastructure and environmental monitoring, though their primary value lies in bridging the gap between EU innovation programmes and the businesses they fund.
What they specialise in
Innovation management and consulting appear as keywords in 6 of 10 projects, spanning the full 2014-2021 timeline.
KAMINO-2 and KAMINO-3 (2019-2021) explicitly add innovation strategy development and life cycle assessment to their scope, indicating deepening advisory services.
EUCANCan (cancer genomics data harmonization) and ESPACE (pancreas cell atlas) show capacity to support health research data management projects.
LANDSENSE (2016-2020) was their largest single project (€191K), focused on citizen observatory platforms for land use monitoring.
How they've shifted over time
In the early period (2014-2017), Steinbeis focused on establishing EEN innovation assessment and consulting services for SMEs, with broader forays into materials research (CREATe-Network) and health innovation ecosystems (DanuBalt). From 2019 onward, their work sharpened significantly around Key Account Management for EIC/SME Instrument beneficiaries, adding explicit innovation strategy development and life cycle assessment capabilities. The health portfolio also matured, moving from regional health innovation networking to concrete cancer genomics data infrastructure (EUCANCan).
Steinbeis is deepening its specialization in post-award support for EIC and SME Instrument beneficiaries, making them an increasingly focused partner for projects that need to bridge EU funding with real business outcomes.
How they like to work
Steinbeis operates exclusively as a participant — they have never coordinated an H2020 project. Despite this, they maintain an unusually broad network of 68 unique partners across 24 countries from just 10 projects, indicating they consistently join large, multinational consortia rather than small focused teams. Their role pattern — low funding shares, CSA-heavy portfolio, and consulting keywords — suggests they serve as the "business translation" partner who ensures project results reach market, rather than driving the research itself.
With 68 unique consortium partners across 24 countries from only 10 projects, Steinbeis has one of the broadest partner-to-project ratios in its class, reflecting their participation in large pan-European consortia. Their network spans most EU member states without a strong geographic concentration beyond their German base.
What sets them apart
Steinbeis brings something rare to EU consortia: deep operational knowledge of how EEN and EIC instruments actually work from the inside, having delivered Key Account Management services across four consecutive project cycles. For consortia that need a partner who understands EU innovation support infrastructure — not just research but the commercialization pipeline — Steinbeis is a natural fit. Their parent network (Steinbeis Foundation) is one of Germany's largest technology transfer ecosystems, giving them access to thousands of SME contacts and transfer centers.
Highlights from their portfolio
- LANDSENSETheir largest single project (€191K, 2016-2020) and an unusual departure from their consulting core — a citizen observatory for environmental monitoring, showing capacity to contribute to technical research platforms.
- EUCANCanA major cancer genomics data infrastructure project (€83K, 2019-2023), demonstrating their ability to support data harmonization and standardization in sensitive health domains.
- KAMINO-3The culmination of their four-project KAMINO series (2015-2021), representing their most refined EEN Key Account Management offering, now covering EIC Accelerator, FTI, and FET-open beneficiaries.